@slavefire61
Active 5 hours, 29 minutes ago
BACKGROUND Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and safety of rivaroxaban in this context are uncertain. METHODS In a double-blind trial, patients with peripheral artery disease who had undergone […] View
-
Salazar Marcus posted an update 5 hours, 29 minutes ago
BACKGROUND Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and safety of rivaroxaban in this context are uncertain. METHODS In a double-blind trial, patients with peripheral artery disease who had undergone revascularization…[Read more]
-
Salazar Marcus became a registered member 5 hours, 46 minutes ago
